Javascript must be enabled to continue!
Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy
View through CrossRef
The recurrence rate of choledocholithiasis in the general population has been reported to exceed 10%. The incidence of cholelithiasis was reported to be higher in patients following gastrectomy than that in the general population. However, there is no study for recurrent choledocholithiasis incidence in patients following gastrectomy. This study aimed to evaluate the recurrence rate of choledocholithiasis and identify risk factors for recurrent choledocholithiasis in patients following gastrectomy. A retrospective analysis was performed on patients with gastrectomy history who underwent choledocholithiasis removal in Kyungpook National University Hospital between January 2011 and December 2019. Choledocholithiases were treated by endoscopic retrograde cholangiopancreatography (ERCP) (n = 41) or percutaneous transhepatic biliary drainage (PTBD) (n = 90). The gastrectomy type was classified as subtotal gastrectomy with Billroth I (18.3%), Billroth II (45.0%), and total gastrectomy with Roux-en-Y (36.6%). During a median follow-up period of 31.5 (range, 6–105) months, choledocholithiasis recurrence was noted in 19 of 131 patients (14.5%). In subgroup analysis, the ERCP group (24.4%) had higher choledocholithiasis recurrence than the PTBD group (10.0%). Stone removal modality (ERCP), no use of balloon sphincteroplasty, and the presence of periampullary diverticulum were significant risk factors for recurrent choledocholithiasis. In multivariate analysis, ERCP (hazard ratio (HR), 3.597; 95% confidence interval (CI): 1.264–10.204) CBD stricture (HR, 3.823; 95% CI: 1.118–13.080) and no use of balloon sphincteroplasty (HR, 4.830; 95% CI: 1.669–13.889) were risk factors for recurrent choledocholithiasis following stone removal. The incidence of CBD stones in patients who underwent gastrectomy is similar to that of the general population. ERCP, CBD stricture, and no use of balloon sphincteroplasty are potential risk factors for recurrent CBD stones following gastrectomy. When we consider PTBD disadvantages, the ERCP procedure with active use of balloon sphincteroplasty is recommended to decrease recurrent CBD stones.
Title: Comparison Study between ERCP and PTBD for Recurrent Choledocholithiasis in Patients Following Gastrectomy
Description:
The recurrence rate of choledocholithiasis in the general population has been reported to exceed 10%.
The incidence of cholelithiasis was reported to be higher in patients following gastrectomy than that in the general population.
However, there is no study for recurrent choledocholithiasis incidence in patients following gastrectomy.
This study aimed to evaluate the recurrence rate of choledocholithiasis and identify risk factors for recurrent choledocholithiasis in patients following gastrectomy.
A retrospective analysis was performed on patients with gastrectomy history who underwent choledocholithiasis removal in Kyungpook National University Hospital between January 2011 and December 2019.
Choledocholithiases were treated by endoscopic retrograde cholangiopancreatography (ERCP) (n = 41) or percutaneous transhepatic biliary drainage (PTBD) (n = 90).
The gastrectomy type was classified as subtotal gastrectomy with Billroth I (18.
3%), Billroth II (45.
0%), and total gastrectomy with Roux-en-Y (36.
6%).
During a median follow-up period of 31.
5 (range, 6–105) months, choledocholithiasis recurrence was noted in 19 of 131 patients (14.
5%).
In subgroup analysis, the ERCP group (24.
4%) had higher choledocholithiasis recurrence than the PTBD group (10.
0%).
Stone removal modality (ERCP), no use of balloon sphincteroplasty, and the presence of periampullary diverticulum were significant risk factors for recurrent choledocholithiasis.
In multivariate analysis, ERCP (hazard ratio (HR), 3.
597; 95% confidence interval (CI): 1.
264–10.
204) CBD stricture (HR, 3.
823; 95% CI: 1.
118–13.
080) and no use of balloon sphincteroplasty (HR, 4.
830; 95% CI: 1.
669–13.
889) were risk factors for recurrent choledocholithiasis following stone removal.
The incidence of CBD stones in patients who underwent gastrectomy is similar to that of the general population.
ERCP, CBD stricture, and no use of balloon sphincteroplasty are potential risk factors for recurrent CBD stones following gastrectomy.
When we consider PTBD disadvantages, the ERCP procedure with active use of balloon sphincteroplasty is recommended to decrease recurrent CBD stones.
Related Results
The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
ObjectiveTo compare the initial success rate, feasibility, and effectiveness of endoscopic retrograde cholangiopancreatography (ERCP) versus percutaneous transhepatic cholangiograp...
Cost-effectiveness of endoscopic ultrasound-directed transgastric ERCP compared with device-assisted and laparoscopic-assisted ERCP in patients with Roux-en-Y anatomy
Cost-effectiveness of endoscopic ultrasound-directed transgastric ERCP compared with device-assisted and laparoscopic-assisted ERCP in patients with Roux-en-Y anatomy
Abstract
Background Roux-en-Y gastric bypass (RYGB) surgery is the second most common weight loss surgery in the United States. Treatment of pancreaticobiliary disease in...
Role of intraductal antibiotic in preventing cholangitis in post-endoscopic retrograde cholangiopancreatography patients
Role of intraductal antibiotic in preventing cholangitis in post-endoscopic retrograde cholangiopancreatography patients
Background
Acute cholangitis is one of the most serious life-threatening post-endoscopic retrograde cholangiopancreatography (ERCP) complications. Some have suggested t...
ERCP application in preoperative complications of pediatric choledochal cyst
ERCP application in preoperative complications of pediatric choledochal cyst
AbstractPurpose Currently, there is no established guideline for the application of ERCP in children with choledochal cyst. This study aimed to investigate the safety and effective...
Cholangiocarcinoma With Sepsis Associated With Percutaneous Transhepatic Biliary Drainage (PTBD)
Cholangiocarcinoma With Sepsis Associated With Percutaneous Transhepatic Biliary Drainage (PTBD)
Percutaneous transhepatic biliary drainage (PTBD) can be an alternative palliative treatment in resectable cholangiocarcinoma. One of the most common complications of PTBD is infec...
1344 Sump Syndrome With Massive Choledocholithiasis Requiring Electrohydraulic Lithotripsy
1344 Sump Syndrome With Massive Choledocholithiasis Requiring Electrohydraulic Lithotripsy
INTRODUCTION:
Cholelithiasis is highly prevalent and affects 10-15% of the United States population. About 10-20% of the patients with symptomatic cholelithiasis have a...
A275 REVISITING THE DIAGNOSTIC YIELD OF ERCP BRUSH CYTOLOGY FOR INDETERMINATE BILIARY STRICTURES
A275 REVISITING THE DIAGNOSTIC YIELD OF ERCP BRUSH CYTOLOGY FOR INDETERMINATE BILIARY STRICTURES
Abstract
Background
Endoscopic Retrograde Cholangiopancreatography (ERCP) brush cytology is the most frequently used tool for sa...
SP6.1.1 Cholecystectomy or expectant management after endoscopic sphincterotomy and bile duct stone removal?
SP6.1.1 Cholecystectomy or expectant management after endoscopic sphincterotomy and bile duct stone removal?
Abstract
Aims
Following ERCP, NICE guidance suggests that surgically fit patients undergo cholecystectomy to prevent recurrence ...

